Sivu 1 alkaen 16 tuloksia
FIELD OF THE INVENTION
The invention relates to methods for detecting an abnormal prostate condition in an animal. Specifically, the invention relates to methods of detecting an abnormal prostate condition in an animal by detecting the amount of Breast Tumor Kinase (BRK) protein present in the
The present invention relates to the compound of formula (I),
##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical
The present invention relates to the compound of formula (I),
##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical
The present invention relates to the compound of formula (I),
##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical
FIELD OF THE INVENTION
The present invention relates to bicyclic heterocycles of the general formula
##STR00002## their tautomers, their stereoisomers, their mixtures and their salts, in particular their physiologically tolerable salts with inorganic or organic acids, which have valuable
This application is the national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2007/061842, filed Nov. 3, 2007, which claims priority to European Application No. 06123820.0, filed Nov. 10, 2006, each of which is hereby incorporated by reference in its entirety.
The
The present invention relates to spirocyclic heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological
The present invention relates to spirocyclic heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological
The present invention relates to cyclohexyloxy-substituted heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable
The present invention relates to cyclohexyloxy-substituted heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable
This application is the national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2008/051141, filed Jan. 30, 2008, which claims priority to European Application No. 07101785.9, filed Feb. 6, 2007, and European Application No. 07118700.9, filed Oct. 17, 2007, each of
The present invention relates to bicyclic heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids which have valuable pharmacological
The present invention relates to bicyclic heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological
FIELD OF INVENTION
This invention relates to bicyclic heterocyclic compounds active as inhibitors of signal transduction mediated by tyrosine kinases. The invention also relates to processes for preparing such compounds and pharmaceutical compositions comprising them.
BACKGROUND OF THE
BACKGROUND OF THE INVENTION
The present invention relates to bicyclic heterocycles of general formula
##STR00002## the tautomers, the stereoisomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have